e.g. Tata motors, Reliance MF, 500570
SUN PHARMACEUTICAL INDUSTRIES LTD. - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Non-Binding Indication Of Interest To Acquire Shares Of Taro Pharmaceutical Industries Ltd., Israel
Download announcement < Back
27 May 2023
On May 26, 2023, Sun Pharmaceutical Industries Limited (&apos;Company&apos;) has issued a letter to the Board of Directors of Taro Pharmaceutical Industries Ltd., Israel (&apos;Taro&apos;) with a proposal containing a non-binding indication of interest to acquire all of the outstanding ordinary shares in Taro, other than any shares already held by the Company or its affiliates (For a purchase price of $38 per ordinary share, in cash the &apos;Proposal&apos;). Copy of the letter containing the Proposal is enclosed herewith as Annexure A. This disclosure is being submitted pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. Source: BSE India